Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Celyad Oncology S.A. CYAD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • BE • USD

SharesGrow Score
51/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

CYAD Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for CYAD.

People Also View

PHVS
PHVS
Pharvaris N.V.
$29.14
+1.60%
 ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
 IPHA
IPHA
Innate Pharma S.A.
$1.69
+3.68%
 PEPG
PEPG
PepGen Inc.
$1.72
+1.78%
 PMVP
PMVP
PMV Pharmaceuticals, Inc.
$1.41
-4.08%
 MNOV
MNOV
MediciNova, Inc.
$1.43
+1.42%
 DYAI
DYAI
Dyadic International, Inc.
$0.88
+0.61%
 NTRBW
NTRBW
Nutriband Inc.
$1.15
+0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message